Sebela Drug Patent Portfolio
Sebela owns 3 orange book drugs protected by 19 US patents Given below is the list of Sebela's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10918516 | Intrauterine device with controlled copper ion elution | 23 Jan, 2037 | Active |
| US11207209 | Intrauterine device with retrieval thread | 16 Aug, 2034 | Active |
| US10166141 | Intrauterine contraceptive device | 13 Jun, 2034 | Active |
| US9265652 | Intrauterine contraceptive device | 28 Apr, 2034 | Active |
| US10022264 | Intrauterine device with retrieval thread | 22 Mar, 2034 | Active |
| US10398588 | Intrauterine device with retrieval thread | 24 Feb, 2034 | Active |
| US9610191 | Intrauterine device with retrieval thread | 24 Feb, 2034 | Active |
| US12138199 | Intrauterine device with retrieval thread | 18 Oct, 2033 | Active |
| US9089418 | Intrauterine contraceptive device | 09 Apr, 2033 | Active |
| US10159596 | Intrauterine contraceptive device | 14 Aug, 2032 | Active |
| US10188546 | Intrauterine device with controlled copper ion elution | 14 Aug, 2032 | Active |
| US11850181 | Intrauterine contraceptive device | 14 Aug, 2032 | Active |
| US9427351 | Intrauterine contraceptive device | 14 Aug, 2032 | Active |
| US8486456 | Itraconazole compositions with improved bioavailability | 03 Oct, 2028 | Active |
| US7598271 | Crystalline paroxetine methane sulfonate | 04 May, 2025 | Expired |
| US5874447 | 4-Phenylpiperidine compounds for treating depression | 10 Jun, 2017 | Expired |
| US6509038 | Antifungal compositions with improved bioavailability | 12 May, 2017 | Expired |
| US7081255 | Antifungal compositions with improved bioavailability | 12 May, 2017 | Expired |
| US8591948 | Antifungal compositions with improved bioavailability | 12 May, 2017 | Expired |
Latest Legal Activities on Sebela's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sebela.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Maintenance Fee Reminder Mailed | 14 Jul, 2025 | US8591948 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 11 Jun, 2025 | US11207209 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Dec, 2024 | US8486456 |
| Mail Patent eGrant Notification | 12 Nov, 2024 | US12138199 |
| Email Notification | 12 Nov, 2024 | US12138199 |
| Recordation of Patent eGrant | 12 Nov, 2024 | US12138199 |
| Patent Issue Date Used in PTA Calculation | 12 Nov, 2024 | US12138199 |
| Patent eGrant Notification | 12 Nov, 2024 | US12138199 |
| Recordation of Patent Grant Mailed | 12 Nov, 2024 | US12138199 |
| Email Notification | 24 Oct, 2024 | US12138199 |
| Issue Notification Mailed | 23 Oct, 2024 | US12138199 |
| Dispatch to FDC | 09 Oct, 2024 | US12138199 |
| Application Is Considered Ready for Issue | 09 Oct, 2024 | US12138199 |
| Issue Fee Payment Received | 08 Oct, 2024 | US12138199 |
| Issue Fee Payment Verified | 08 Oct, 2024 | US12138199 |
Sebela's Family Patents
Sebela Drug List
Given below is the complete list of Sebela's drugs and the patents protecting them.
1. Miudella
Miudella is protected by 13 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10918516 | Intrauterine device with controlled copper ion elution |
23 Jan, 2037
(10 years from now)
| Active |
| US11207209 | Intrauterine device with retrieval thread |
16 Aug, 2034
(8 years from now)
| Active |
| US10166141 | Intrauterine contraceptive device |
13 Jun, 2034
(8 years from now)
| Active |
| US9265652 | Intrauterine contraceptive device |
28 Apr, 2034
(8 years from now)
| Active |
| US10022264 | Intrauterine device with retrieval thread |
22 Mar, 2034
(8 years from now)
| Active |
| US10398588 | Intrauterine device with retrieval thread |
24 Feb, 2034
(7 years from now)
| Active |
| US9610191 | Intrauterine device with retrieval thread |
24 Feb, 2034
(7 years from now)
| Active |
| US12138199 | Intrauterine device with retrieval thread |
18 Oct, 2033
(7 years from now)
| Active |
| US9089418 | Intrauterine contraceptive device |
09 Apr, 2033
(7 years from now)
| Active |
| US10159596 | Intrauterine contraceptive device |
14 Aug, 2032
(6 years from now)
| Active |
| US10188546 | Intrauterine device with controlled copper ion elution |
14 Aug, 2032
(6 years from now)
| Active |
| US11850181 | Intrauterine contraceptive device |
14 Aug, 2032
(6 years from now)
| Active |
| US9427351 | Intrauterine contraceptive device |
14 Aug, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Miudella's drug page
2. Onmel
Onmel is protected by 4 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8486456 | Itraconazole compositions with improved bioavailability |
03 Oct, 2028
(2 years from now)
| Active |
| US6509038 | Antifungal compositions with improved bioavailability |
12 May, 2017
(8 years ago)
| Expired |
| US7081255 | Antifungal compositions with improved bioavailability |
12 May, 2017
(8 years ago)
| Expired |
| US8591948 | Antifungal compositions with improved bioavailability |
12 May, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Onmel's drug page
3. Pexeva
Pexeva is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7598271 | Crystalline paroxetine methane sulfonate |
04 May, 2025
(10 months ago)
| Expired |
| US5874447 | 4-Phenylpiperidine compounds for treating depression |
10 Jun, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pexeva's drug page